Published in Am J Epidemiol on December 22, 2013
Pre-operative Risk Assessment of Surgical Site Infection After Cardiac Surgery | NCT04762446
The Stroke Riskometer(TM) App: validation of a data collection tool and stroke risk predictor. Int J Stroke (2014) 2.18
Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA (2014) 1.36
Sixty-five common genetic variants and prediction of type 2 diabetes. Diabetes (2014) 1.21
External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges. BMJ (2016) 0.96
Multivariate meta-analysis of individual participant data helped externally validate the performance and implementation of a prediction model. J Clin Epidemiol (2015) 0.89
Summarising and validating test accuracy results across multiple studies for use in clinical practice. Stat Med (2015) 0.85
Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis. Lancet Diabetes Endocrinol (2016) 0.78
Covariate-adjusted measures of discrimination for survival data. Biom J (2014) 0.77
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med (2008) 57.29
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med (1996) 46.18
Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ (2009) 19.23
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet (2007) 15.27
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med (2010) 14.49
Evaluating the yield of medical tests. JAMA (1982) 14.05
Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol (1997) 9.25
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet (2011) 9.07
How should meta-regression analyses be undertaken and interpreted? Stat Med (2002) 8.96
Assessing the generalizability of prognostic information. Ann Intern Med (1999) 8.04
Cancer Incidence in BRCA1 mutation carriers. J Natl Cancer Inst (2002) 6.58
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26
Multivariate meta-analysis: potential and promise. Stat Med (2011) 5.26
A new measure of prognostic separation in survival data. Stat Med (2004) 4.98
On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med (2011) 4.34
Interpretation of random effects meta-analyses. BMJ (2011) 4.32
Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies. Int J Epidemiol (2010) 3.97
Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Stat Med (2004) 3.93
Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol (2006) 3.41
Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries. Lancet (2004) 2.80
The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med (2006) 2.74
The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol (2008) 2.73
Diet and cancer--the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer (2004) 2.24
Measures to assess the prognostic ability of the stratified Cox proportional hazards model. Stat Med (2009) 2.23
Matching in studies of classification accuracy: implications for analysis, efficiency, and assessment of incremental value. Biometrics (2007) 1.88
Choice of time scale and its effect on significance of predictors in longitudinal studies. Stat Med (2007) 1.84
Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer. Stat Med (2004) 1.36
A global goodness-of-fit statistic for Cox regression models. Biometrics (1999) 1.19
Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease. Am J Epidemiol (2012) 1.13
Prognostic scores for detecting a high risk group: estimating the sensitivity when applied to new data. Stat Med (1990) 0.83
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ (2009) 19.23
Multiple imputation using chained equations: Issues and guidance for practice. Stat Med (2010) 17.36
Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med (2014) 12.79
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet (2009) 11.81
Major lipids, apolipoproteins, and risk of vascular disease. JAMA (2009) 10.58
Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med (2011) 10.33
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet (2011) 9.07
Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med (2010) 7.83
Controlling the risk of spurious findings from meta-regression. Stat Med (2004) 6.80
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc (2009) 5.81
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA (2009) 5.63
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals. Clin Trials (2004) 5.26
Multivariate meta-analysis: potential and promise. Stat Med (2011) 5.26
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet (2016) 4.49
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet (2010) 4.46
Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med (2008) 4.34
Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies. Int J Epidemiol (2010) 3.97
Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J (2005) 3.89
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Sensitivity analysis after multiple imputation under missing at random: a weighting approach. Stat Methods Med Res (2007) 3.67
Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ (2011) 3.65
Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res (2011) 3.56
A sustained mortality benefit from screening for abdominal aortic aneurysm. Ann Intern Med (2007) 3.27
Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials (2005) 3.19
Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation (2004) 3.07
Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med (2010) 3.07
Endovascular or open repair strategy for ruptured abdominal aortic aneurysm: 30 day outcomes from IMPROVE randomised trial. BMJ (2014) 2.98
Time of birth and risk of neonatal death at term: retrospective cohort study. BMJ (2010) 2.74
Bias modelling in evidence synthesis. J R Stat Soc Ser A Stat Soc (2009) 2.74
Adjusting for partially missing baseline measurements in randomized trials. Stat Med (2005) 2.70
How should variable selection be performed with multiply imputed data? Stat Med (2008) 2.65
Methodological challenges in online trials. J Med Internet Res (2009) 2.64
Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews. Int J Epidemiol (2012) 2.58
Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med (2012) 2.52
Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA (2008) 2.52
Mediation and moderation of treatment effects in randomised controlled trials of complex interventions. Stat Methods Med Res (2009) 2.43
Poorer self assessed health in a prospective study of men with screen detected abdominal aortic aneurysm: a predictor or a consequence of screening outcome? J Epidemiol Community Health (2004) 2.42
Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol (2013) 2.34
Review of statistical methods for analysing healthcare resources and costs. Health Econ (2010) 2.27
Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies. Int J Epidemiol (2006) 2.22
Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants. J Am Coll Cardiol (2010) 2.20
Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control (2006) 2.17
Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol (2015) 2.14
A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophr Res (2011) 2.09
Dietary fiber and colorectal cancer risk: a nested case-control study using food diaries. J Natl Cancer Inst (2010) 2.07
Use of allele scores as instrumental variables for Mendelian randomization. Int J Epidemiol (2013) 2.06
The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One (2013) 1.95
Randomised controlled trial of acute mental health care by a crisis resolution team: the north Islington crisis study. BMJ (2005) 1.94
Endovascular repair of aortic aneurysm in patients physically ineligible for open repair. N Engl J Med (2010) 1.92
Clustering by health professional in individually randomised trials. BMJ (2005) 1.85
Second-trimester maternal serum levels of alpha-fetoprotein and the subsequent risk of sudden infant death syndrome. N Engl J Med (2004) 1.78
Mode of delivery and the risk of delivery-related perinatal death among twins at term: a retrospective cohort study of 8073 births. BJOG (2005) 1.76
Imputation methods for missing outcome data in meta-analysis of clinical trials. Clin Trials (2008) 1.76
Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol (2011) 1.75
Use of Mendelian randomisation to assess potential benefit of clinical intervention. BMJ (2012) 1.70
Correcting for optimistic prediction in small data sets. Am J Epidemiol (2014) 1.69
Outcomes of crises before and after introduction of a crisis resolution team. Br J Psychiatry (2005) 1.68
Can 16-detector multislice CT exclude skeletal lesions during tumour staging? Implications for the cancer patient. Eur Radiol (2006) 1.66
The effect of measurement error in risk factors that change over time in cohort studies: do simple methods overcorrect for 'regression dilution'? Int J Epidemiol (2005) 1.66
Impact and costs of incentives to reduce attrition in online trials: two randomized controlled trials. J Med Internet Res (2011) 1.66
On-line randomized controlled trial of an internet based psychologically enhanced intervention for people with hazardous alcohol consumption. PLoS One (2011) 1.61